Industries > Life Sciences & Healthcare > Life Sciences & Healthcare Competitive Intelligence (CI) Services

Life Sciences & Healthcare Competitive Intelligence (CI) Services

We assist you in gauging the potential danger of new entrants, monitoring the activities of existing competitors and technological developments, monitoring the health and purchasing power of suppliers and consumers, and investigating the availability of replacements and the commercial effect of a shifting market.

Blogs | Why is Healthcare Data Quality Critical in the Age of AI

Why Do You Need Competitive Intelligence for the Life Sciences and Healthcare Industries?

How can you tell them apart when comparing "information" and "intelligence"? By leveraging CI techniques, SG Analytics (SGA) can transform data with intelligence into insights that drive growth, generate new income, and improve company strategy.  At SGA, we begin with information we know to be accurate and reliable. The public now has access to a wealth of numerical and statistical information on patients, businesses, pharmaceuticals, medical equipment, and patient preferences thanks to the digitization of payer and provider data. Understanding the underlying substance of data and market trends has become more difficult due to information overload. Only when information is put into context and checked for reporting bias can we call it "intelligent."  Read More
Healthcare Competitive Intelligence Services

What We Offer

SGA understands your end goal and the objective for the exercise before creating a work plan for life sciences & healthcare competitive intelligence projects. Our experts speak your language and understand the threats, opportunities, challenges, and strengths of different therapeutic segments. 

Our experts understand and map peers on company and product levels. We track 5,000 pharmaceutical companies and 800 key medical device companies daily and understand their launch strategies, pipelines, and roadmaps. Our AI/ML tools (proprietary) are time-tested to gather information quickly from the desired market. 

Our team of data analysts is proficient in data crawling, data gathering, data cleansing, and data sorting before interpreting the insights from the most relevant information.

SGA's analyst team has been supporting clients for strategy execution by actionable insights on products, peers, and market perceptions. 


Industry Leaders

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With


Whitepaper Market Entry in 2023

White Papers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

Whitepaper Blue Ocean Strategy

White Papers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

White Papers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in equal opportunity for all. Our research team consists of more females than males, i.e., 55males, and comprises PhDs, M Pharms, D Pharms, Postgraduates in Finance and Biotech, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high quality, white labelled research coverage.